For gliomas, HCP5 has been demonstrated to affect the malignant behavior of glioma cells via interacting with a tumor suppressor, miR-139, along with the alteration of Runt-related transcription factor 1 [17]. This evidence concerns the gene HCP5 and central nervous system cancer.